13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 44 holding rows worth $599,558,377.
- Accession
- 0001493152-24-045811
- Filer
- CIK 1595855
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 44 entries on the cover page, a total value of $599,558,377 stated on the cover page (in dollars after the unit check, H1), rows summing to $599,558,377 with VALUE read as dollars as filed, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HARROW INC | 415858109 | COM | 3,990,000 | $179,390,400 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 2,280,000 | $53,329,200 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,025,000 | $43,717,500 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,255,000 | $30,910,650 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 8,770,000 | $27,011,600 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 500,000 | $26,195,000 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 395,276 | $22,953,677 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 1,237,500 | $18,092,250 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,698,142 | $16,981,420 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 2,780,000 | $16,680,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 522,500 | $13,945,525 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 541,437 | $11,834,513 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,320,000 | $11,220,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 85,000 | $9,712,950 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 420,000 | $9,437,400 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 1,893,660 | $9,335,744 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,567,990 | $8,577,087 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 3,815,000 | $6,970,700 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 820,202 | $6,684,646 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 353,500 | $6,649,335 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 250,000 | $6,620,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 64,000 | $6,547,200 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 335,000 | $5,561,000 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 404,100 | $5,132,070 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 105,000 | $4,725,000 | dollars as filed | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 8,000,000 | $4,188,928 | dollars as filed | principal |
| CYTOKINETICS INC | 23282W605 | COM NEW | 75,300 | $3,975,840 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 6,000,000 | $3,960,672 | dollars as filed | principal |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 3,665,010 | $3,705,692 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 967,000 | $3,558,560 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,681,154 | $3,076,512 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 466,563 | $2,262,831 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 112,500 | $2,236,500 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 800,000 | $2,080,000 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 1,395,000 | $1,925,100 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,407,600 | $1,572,644 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 480,000 | $1,555,200 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 179,200 | $1,532,331 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 275,000 | $1,427,250 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 654,943 | $1,408,127 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 440,000 | $919,600 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 535,000 | $839,950 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 375,000 | $832,500 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 110,571 | $285,273 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-24-045811 | this filing | 2024-11-14 | acceptance time not in the bulk data set |